• Login
    View Item 
    •   IIMA Institutional Repository Home
    • Video Library
    • R & P Seminar
    • View Item
    •   IIMA Institutional Repository Home
    • Video Library
    • R & P Seminar
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Counterfeit avastin in India: punish the criminals, not the patients

    Thumbnail
    View/Open
    RP_Jan_10_2020_1 (957bytes)
    RP_Jan_10_2020_2 (956bytes)
    Date
    2020-01-10
    Author
    Narayanan, Raja
    Metadata
    Show full item record
    Abstract
    In December, 2015, 15 cases of intraocular inflammation following injections of counterfeit bevacizumab occurred in Gujarat, India. CDSCO reacted by prohibiting the use of intraocular bevacizumab throughout the country. Intense negotiations between the VRSI and CDSCO resulted in the permission to use bevacizumab in accordance with new safety guidelines. These include an enhanced informed consent process, the stamping of the Kezzler code on all bevacizumab vials, a real-time digital verification process between the end user and Roche Pharmaceuticals, and mandatory destruction of empty drug vials. Counterfeit bevacizumab has caused outbreaks of sterile and infectious post injection endophthalmitis in at least 3 countries during the past 5 years and has entered the supply chain in other countries. Physicians and compounding pharmacists need to be aware that international counterfeiters have targeted bevacizumab.
    URI
    http://hdl.handle.net/11718/23363
    Collections
    • R & P Seminar [209]

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of IIMA Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    Statistics

    View Usage Statistics

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV